Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Urol
Hlavní autoři: Pilskog, Martin, Beisland, Christian, Akslen, Lars A., Bostad, Leif, Haug, Åse, Heinrich, Daniel, Hjelle, Karin M., Straume, Oddbjørn
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580299/
https://ncbi.nlm.nih.gov/pubmed/28859644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0267-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky